GI side effects

GLP-1 constipation: why it happens, and how to fix it

Constipation is one of the most common GLP-1 side effects — and it tends to last longer than nausea. Here's the mechanism, the real trial numbers, a step-by-step relief protocol, and the rare red flags that mean “call a doctor now.”

Written byGLP1Zoom Editorial, Medical content team · Independent editorial

Medically reviewed byGLP1Zoom Editorial Team, Evidence-based editorial review Reviewed Jun 10, 2026

Verified Jul 2026 · re-checked quarterlyBy the GLP1Zoom editorial teamWe compare, we don’t sell

The short answer

GLP-1s slow the gut on purpose(that's part of how they curb appetite), so stool moves slower and dries out — and eating/drinking less compounds it. It affected ~24% on semaglutide 2.4 mg vs 11% on placebo in trials, and lasts longer than nausea. Fix it with fluid + fiber + movement, then osmotic laxatives if needed. Rare but urgent: severe pain, a distended belly, or no gas/stool can signal a blockage.

Key takeaways

Cause: GLP-1s slow gastric emptying and gut transit (part of the appetite effect), so stool moves slower and loses water; eating and drinking less compounds it.
Frequency: ~24% on semaglutide 2.4mg (Wegovy) vs 11% placebo; ~11-17% on tirzepatide (Zepbound). Median duration ~47 days in the Wegovy trials — longer than nausea.
First-line relief: more fluid, gradual fiber increase (with water), and daily movement. Then osmotic laxatives (polyethylene glycol/MiraLAX, magnesium) or a stool softener if needed.
Increase fiber slowly and with fluid — adding fiber without water can worsen it.
Red flags (rare ileus/obstruction, a labeled risk): severe/worsening abdominal pain, distended belly, no gas or stool, or persistent vomiting = urgent care.

Why GLP-1s cause constipation

The mechanism is the medication working as intended. GLP-1 receptor agonists slow how quickly the stomach empties, which prolongs fullness and reduces appetite. That slowing continues through the intestines: the slower stool moves, the more water the colon reabsorbs from it, leaving it harder and less frequent. Layer on the appetite suppression — less food, less fiber, and less fluid — and constipation is a predictable result. It shows up across the class, so the same pattern applies to Ozempic, Wegovy, Mounjaro, Zepbound, and compounded versions.

How common — and how long — is it?

Constipation is one of the most frequent side effects, and it is dose-related. From the FDA labels and pivotal trials:

Medication	Constipation	Placebo
Semaglutide 2.4 mg (Wegovy)	~24%	~11%
Tirzepatide (Zepbound)	~11–17%	~5%

One detail people miss: in the Wegovy trials, constipation had a longer median duration (about 47 days) than nausea, vomiting, or diarrhea. So while nausea often fades within a week or two, constipation can linger — which is why an ongoing routine, not a one-off fix, matters. See the full side-effect breakdown in our GLP-1 side effects guide.

A step-by-step relief protocol

Step 1 — Fluid first

Dehydration is a leading driver. Drink enough that your urine is pale yellow; warm fluids in the morning can help stimulate a bowel movement.

Step 2 — Fiber, increased slowly

Build up fruits, vegetables, and whole grains, or add a soluble-fiber supplement (psyllium). Increase gradually and with plenty of water — fiber without fluid can backfire (AGA).

Step 3 — Move daily

Even a walk after meals helps gut motility. Regular activity is one of the simplest, best-supported measures for constipation.

Step 4 — OTC options, if needed

A clinician or pharmacist may suggest an osmotic laxative (polyethylene glycol/MiraLAX or magnesium) or a stool softener. Stimulant laxatives are generally short-term only.

When it's an emergency

Very rarely, slowed gut motility can progress to a blockage (ileus or bowel obstruction) — a risk noted on GLP-1 labels. Get urgent care for:

Severe or worsening abdominal pain
A swollen, distended, or hard belly
Inability to pass gas or stool
Persistent vomiting

Also see a clinician for constipation lasting over a week despite treatment, blood in the stool, or unexplained weight change — don't just keep adding laxatives.

This page is educational, dated 2026-07-17, and not medical advice. Persistent or severe symptoms should be assessed by your prescriber or a clinician.

A provider who manages side effects with you

Common questions about GLP-1 constipation

Why do GLP-1 medications cause constipation?

GLP-1 medications (semaglutide in Ozempic/Wegovy, tirzepatide in Mounjaro/Zepbound) deliberately slow how fast the stomach empties, which is part of how they curb appetite. That same slowing extends through the gut, so stool moves more slowly and more water is reabsorbed, leaving it harder and less frequent. On top of that, appetite suppression usually means you eat less food, less fiber, and drink less fluid — all of which compound constipation. It is one of the most common side effects and, unlike nausea, tends to last longer.

How common is constipation on Ozempic and Wegovy?

It is common and dose-related. In the pivotal weight-loss trials, constipation affected about 24% of adults on semaglutide 2.4 mg (Wegovy) versus about 11% on placebo, and roughly 11-17% on tirzepatide (Zepbound) versus about 5% on placebo (FDA labels). Notably, in the Wegovy trials constipation had a longer median duration (around 47 days) than nausea, vomiting, or diarrhea — so it can be a more persistent nuisance even though it is rarely dangerous.

How do I relieve GLP-1 constipation?

Start with the basics that address the mechanism: drink more fluid (aim for pale-yellow urine), gradually increase dietary fiber (fruits, vegetables, whole grains) or a soluble-fiber supplement, and move your body daily — walking helps gut motility. If that is not enough, over-the-counter options your clinician or pharmacist may suggest include an osmotic laxative such as polyethylene glycol (MiraLAX) or magnesium, and a stool softener; stimulant laxatives are usually short-term only. Increase fiber slowly and with plenty of water, since adding fiber without fluid can make things worse.

When is constipation on a GLP-1 an emergency?

Rarely, the slowed gut can progress to a serious blockage (ileus or bowel obstruction), which GLP-1 labels list as a possible risk. Seek urgent medical care if you have severe or worsening abdominal pain, a swollen or distended belly, an inability to pass gas or stool, or persistent vomiting. Constipation that lasts more than a week despite treatment, or that comes with blood in the stool or unexplained weight change, also warrants prompt medical attention rather than more laxatives.

Does GLP-1 constipation go away over time?

For many people it eases as the body adjusts, and it is usually worst during the early weeks and after each dose increase. Slower dose escalation, staying ahead of it with fluid and fiber, and not skipping movement all help. If it stays disruptive, your prescriber can adjust the titration pace or discuss options — you do not have to just tolerate it. Any medication change should be made with your clinician.

Sources

Frequencies and durations from the FDA-approved Wegovy/Zepbound labels and the NEJM STEP 1 trial; management from the American Gastroenterological Association; the ileus/obstruction caution from the FDA labels and peer-reviewed review. Reviewed 2026-07-17. Educational only — not medical advice.

References(5)

Our sourcing standards →

Wegovy (semaglutide 2.4 mg) Prescribing Information — Adverse Reactions (constipation ~24% vs 11% placebo)NIH — US FDA label via DailyMed (2026)
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1, adverse-event profile & durations)NEJM — New England Journal of Medicine (Wilding et al.) (2021)
American Gastroenterological Association — Constipation: evaluation and management — AGA (patient resources) (2024)
GLP-1 receptor agonists, delayed gastric emptying, and ileus — clinical cautionNCBI — PMC (peer-reviewed review) (2023)